WELCOME TO

3Sixty Biopharmaceuticals

3Sixty Biopharmaceuticals is a SAHPRA licensed pharmaceutical company with a number of local and international partners with a broad base of  pharmaceutical  products which address unmet medical needs.

Mr. Walter Mbatha

3Sixty Biopharmaceuticals CEO

Message from our CEO

3Sixty Biopharmaceuticals is an ambitious pharmaceutical company in South Africa which is geared for a Global footprint in the Biotech space. 3Sixty Biopharmaceuticals is a subsidiary of 3Sixty Health Solutions and 3Sixty Global Solutions Group which share a common vision of being solutions driven towards humankind’s health challenges through the development and distribution of scientifically & clinically proven innovative products.

As a business, we embody the spirit of Ubuntu, which drives our global vision of being at the centre of healthcare solutions that enable us to empower and contribute in the development of the South African economy.

The range of our products and service offering through the strategic partnerships both locally and internationally affirms our commitment for delivering safe, high quality, innovative and cost-effective medicines to all sectors of society, in turn improving their access to a much needed quality healthcare.

3Sixty Biopharmaceuticals is an ambitious pharmaceutical company in South Africa which is geared for a Global footprint in the Biotech space.
3Sixty Biopharmaceuticals is a subsidiary of 3Sixty Health Solutions and
3Sixty Global Solutions Group which share a common vision of being solutions driven towards humankind’s health challenges through the development and distribution of scientifically & clinically proven innovative products.

Read More

As a business, we embody the spirit of Ubuntu, which drives our global vision of being at the centre of healthcare solutions that enable us to empower and contribute in the development of the South African economy.

The range of our products and service offering through the strategic partnerships both locally and internationally  affirms our commitment for delivering safe, high quality, innovative and cost-effective medicines to all sectors of society, in turn improving their access to a much needed quality healthcare.

Latest News

3SixtyBiopharma has signed an exclusive distribution agreement for the distribution of air purification systems in Africa. Airocide, originally developed by NASA has the potential to combat airborne pathogens & could be key in the fight against covid-19, as positive cases rise.

Not only do people have to deal with their own anxiety, stress and frustration, they also have to contend with the stigma attached to infertility. The Infertility Awareness Association of South Africa is hosting a number of webinars to mark National Infertility Awareness Week. Walter Mbatha from 3Sixty Biomedicine has more on this.

Our Products

Salome Fertility

Canotria

Tenagril

Salome Menstrual Pain

Salome Fertility

Canotria

Tenagril

Salome Menstrual Pain

Our Strategic Partners

Developing local and international symbiotic relationships is an important part of our growth strategy.
These strategic relationships have developed into strong partnerships in new product creation, adding new skills and services into our already extensive operations.

Our partnerships have allowed us to develop “best of breed” solutions for our customers and clients. These partnerships have also enabled us to introduce unique knowledge-base and experience from other countries where technologies and methodologies differ from our own.

Our Strategic Partners

Developing local and international symbiotic relationships is an important part of our growth strategy.
These strategic relationships have developed into strong partnerships in new product creation, adding new skills and services into our already extensive operations.

Our partnerships have allowed us to develop “best of breed” solutions for our customers and clients. These partnerships have also enabled us to introduce unique knowledge-base and experience from other countries where technologies and methodologies differ from our own.